Outcomes | DCC | DCM-B | DCM-A | p |
---|---|---|---|---|
Peak bilirubin level, mg/dL (mean ± SD) | 9.5 ± 2.7 | 9.5 ± 2.4 | 9.7 ± 1.9 | 0.07 |
Phototherapy (n, %) | 39 (97.5) | 37 (92.5) | 35 (87.5) | < 0.01 |
Duration of phototherapy, days (mean ± SD) | 6.2 ± 3.3 | 5.5 ± 4.5 | 4.8 ± 3.2 | 0.16 |
Respiratory distress syndrome (n, %) | 19 (47.5) | 12 (30) | 10 (25) | 0.67 |
Surfactant (n, %) | 12 (30) | 8 (20) | 5 (12.5) | 0.13 |
Patent ductus arteriosus (n, %) | 12 (30) | 8 (20) | 7 (17.5) | 0.48 |
Bronchopulmonary dysplasia (n, %) | 18 (45) | 11 (27.5) | 6 (15) | 0.01 |
Ventilator, days (mean ± SD) | 3.6 ± 9.2 | 1.6 ± 3.7 | 0.5 ± 1.7 | < 0.01 |
Oxygen therapy, days (mean ± SD) | 28.6 ± 30 | 16.1 ± 18.0 | 10.1 ± 14.6 | < 0.01 |
Intraventricular hemorrhage Grade I (n, %) | 12 (30) | 6 (15) | 13 (32.5) | 0.22 |
Necrotizing enterocolitis (n, %) | 3 (7.5) | 0 | 4 (10) | 0.78 |
Length of hospital stay, days (mean ± SD) | 42.7 ± 29.2 | 31.7 ± 18.9 | 26 ± 15.3 | 0.01 |